The activity of cyclin-dependent kinases (cdks) depends on the phosphorylation of a residue corresponding to threonine 161 in human p34cdc2. One enzyme responsible for phosphorylating this critical residue has recently been purified from Xenopus and starfish. It was termed CAK (for cdk-activating kinase), and it was shown to contain p40MO15 as its catalytic subunit. In view of the cardinal role of cdks in cell cycle control, it is important to learn if and how CAK activity is regulated during the somatic cell cycle. Here, we report a molecular characterization of a human p40MO15 homologue and its associated CAK activity. We have cloned and sequenced a cDNA coding for human p40MO15, and raised specific polyclonal and monoclonal antibodies against the corresponding protein expressed in Escherichia coli. These tools were then used to demonstrate that p40MO15 protein expression and CAK activity are constant throughout the somatic cell cycle. Gel filtration suggests that active CAK is a multiprotein complex, and immunoprecipitation experiments identify two polypeptides of 34 and 32 kD as likely complex partners of p40MO15. The association of the three proteins is near stoichiometric and invariant throughout the cell cycle. Immunocytochemistry and biochemical enucleation experiments both demonstrate that p40MO15 is nuclear at all stages of the cell cycle (except for mitosis, when the protein redistributes throughout the cell), although the p34cdc2/cyclin B complex, one of the major purported substrates of CAK, occurs in the cytoplasm until shortly before mitosis. The absence of obvious changes in CAK activity in exponentially growing cells constitutes a surprise. It suggests that the phosphorylation state of threonine 161 in p34cdc2 (and the corresponding residue in other cdks) may be regulated primarily by the availability of the cdk/cyclin substrates, and by phosphatase(s).
Skip Nav Destination
Article navigation
15 October 1994
Article|
October 15 1994
Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase).
J P Tassan,
J P Tassan
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
Search for other works by this author on:
S J Schultz,
S J Schultz
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
Search for other works by this author on:
J Bartek,
J Bartek
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
Search for other works by this author on:
E A Nigg
E A Nigg
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
Search for other works by this author on:
J P Tassan
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
S J Schultz
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
J Bartek
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
E A Nigg
Swiss Institute for Experimental Cancer Research (ISREC), Epalinges.
Online ISSN: 1540-8140
Print ISSN: 0021-9525
J Cell Biol (1994) 127 (2): 467–478.
Citation
J P Tassan, S J Schultz, J Bartek, E A Nigg; Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase).. J Cell Biol 15 October 1994; 127 (2): 467–478. doi: https://doi.org/10.1083/jcb.127.2.467
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement